Forge Therapeutics

At Forge Therapeutics, we are developing novel antibiotics by targeting bacterial metalloenzymes using innovative chemistry.

[Working to Fight AMR @WeFightAMR]

Leaders from across the healthcare sector met yesterday to discuss the importance of bolstering the antibiotic pipeline to keep up with the threat of #superbugs. Watch their recommendations for staying ahead of #AMR.
https://t.co/zHkGefQZ0J

[Forge Therapeutics @ForgeThera]

As antimicrobial resistance (#AMR) continues to spread and become deadlier, the need for new drugs has never been clearer. We're glad to be part of today’s discussion at #MIGlobal https://t.co/jZ77VJELU6 #biotech

[Forge Therapeutics @ForgeThera]

We’re excited to be participating in the Milken Institute Global Conference! Tune in tomorrow to hear Forge CSO Andrew Tomaras discuss how we’re working to combat #AMR through innovation. https://t.co/jZ77VJELU6 #MIGlobal

[Forge Therapeutics @ForgeThera]

Forge Therapeutics achieves CARB-X milestone for FG-LpxC LUNG antibiotic program! https://t.co/ZEcERJ6Nil

#biotech #business #drugdevelopment

[Rachel King 🧬 @IamBIO_CEO]

Read my latest in @sdut with @ForgeThera Chief Scientific Officer Dr. Andrew Tomaras about #AntimicrobialResistance – and the importance of shaping policy that supports research, development and production of new #antibiotics https://t.co/FDMR1FUGEz

[Forge Therapeutics @ForgeThera]

We’re pleased to announce the appointment of Peter Warn, Ph.D., to the Forge Therapeutics Antibiotic Advisory Board! An experienced antimicrobial discovery scientist, Dr. Warn brings to Forge a long and successful record of working in the anti-infective discovery industry.

[Forge Therapeutics @ForgeThera]

Please join us in congratulating John Rex on his new position as the SAB chair of the AMR Action Fund! Dr. Rex has dedicated years of service to Forge, helping shape our strategy of developing truly novel antibiotics. #leadership #AMR

[AMR Action Fund @AMRActionFund]

We're happy to announce @JohnRex_NewAbx’s appointment as Chair of our Scientific Advisory Board. Dr. Rex brings over 30 years of drug development and policy experience focused on antimicrobial agents. https://t.co/wcIQVgjUUE #AMR #AntimicrobialResistance

[Forge Therapeutics @ForgeThera]

We are pleased to announce the appointment of Dr. Andrew Tomaras as Chief Scientific Officer! Dr. Tomaras will be responsible for advancing Forge’s pipeline of novel antibiotics into the clinic along with directing other anti-infective efforts. https://t.co/MnqeHsWj3I #leadership

[Forge Therapeutics @ForgeThera]

https://t.co/f37i6yXKDj

[Forge Therapeutics @ForgeThera]

We're excited to welcome Lloyd Payne, Ph.D., one of the world's leading antibiotic KOLs, to our Antibiotic Advisory Board! Dr. Payne is Founding CEO of specialty anti-infective CRO Euprotec, EVP & Head of Anti-Infectives at Evotec and on NOVO Repair’s Scientific Selection Board.

[Forge Therapeutics @ForgeThera]

Congrats to our scientific co-founder Seth Cohen, Ph.D. for making such a prestigious list!

52 UC San Diego Researchers Are Named Highly Cited in 2020 Listing https://t.co/ypQGpXfGfi

[Forge Therapeutics @ForgeThera]

During COVID, the growing dangers and threat posed by antibiotic-resistant bacteria outweigh the global level of preparedness. Meanwhile, antibiotic R&D is suffering for investment. Forge applauds @Merck and Kyorin for supporting @PewCharitableTrust https://t.co/i0ToNjccgt

[Forge Therapeutics @ForgeThera]

https://t.co/mK4v0oWD55

[Forge Therapeutics @ForgeThera]

Check it out! Today and tomorrow, we will be discussing the future of antibiotic development alongside @CARB_X and @Roche at this month’s World Antimicrobial Resistance Congress 2020. https://t.co/Yf6aEw2hC6 #antibiotics #drugdiscovery #AMR #StopAMR

[Forge Therapeutics @ForgeThera]

Racing the clock to stop drug-resistant superbugs https://t.co/egfQqMgsRC via @BostonGlobe

[Forge Therapeutics @ForgeThera]

Help us win the fight against #AMR! Click below to help pass the DISARM Act to make new antibiotics available to patients.

[Working to Fight AMR @WeFightAMR]

Antimicrobial resistance #AMR is building into a new #pandemic. One way to fight it? The DISARM Act. Contact Congress and help pass this lifesaving legislation by clicking here: https://t.co/BYoB3icVOy

[Forge Therapeutics @ForgeThera]

5 Facts About the Stagnant Antibiotic Pipeline https://t.co/thjEI4OyWS via @YouTube

[IFPMA @IFPMA]

Society desperately needs new antibiotics but, right now, there is no viable market for them. We’re joining others in backing a new $1 billion @AMRActionFund that aims to bring 2 to 4 new antibiotics to patients by 2030.

Press release: https://t.co/Pi30uZY3He

[Roche @Roche]

#COVID19 has shown us that global health crises need truly global responses. That’s why we are committed to the @AMRActionFund alongside @IFPMA to #StopAMR. Learn more: https://t.co/SNsjM73yo2

#StrongerTogether
#AntimicrobialResistance #AMR

[CARB-X @CARB_X]

*GREAT NEWS* -- The pharma industry is launching a $1-billion @AMRActionFund to develop antibiotics. The goal is to deliver 2-4 new drugs by the end of the decade to save modern medicine from deadly drug-resistant infections.

https://t.co/Wi6zrgv76O